Champions Oncology, Inc.

Historical 13F Holders

Symbol
CSBR
CUSIP
15870P307
All holders as of
Q2 2026
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 15870P307 since 12/18/2024, largest first.

Filer % of Class Filed
Under 5%, checked the "5 percent or less" box, or amended by a later filing (1)
Tocqueville Asset Management L.P. 13G/A
4.4% 2/14/2025
Event 12/31/2024

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q2 29 5.90 M $36.4 M
2026 Q1 26 5.73 M $33.0 M
2025 Q4 28 5.75 M $39.7 M
2025 Q3 28 5.66 M $36.7 M
2025 Q2 34 5.78 M $42.6 M
2025 Q1 38 5.92 M $51.4 M
2024 Q4 29 5.72 M $49.0 M
2024 Q3 25 5.78 M $28.2 M
2024 Q2 28 5.82 M $30.1 M
2024 Q1 31 5.72 M $28.0 M
2023 Q4 30 5.62 M $31.5 M
2023 Q3 33 5.74 M $35.6 M
2023 Q2 34 5.81 M $37.0 M
2023 Q1 33 5.86 M $23.6 M
2022 Q4 33 6.03 M $27.2 M
2022 Q3 36 6.24 M $46.8 M
2022 Q2 35 6.22 M $49.8 M
2022 Q1 33 6.20 M $50.4 M
2021 Q4 32 6.21 M $51.7 M
2021 Q3 36 6.28 M $64.1 M
2021 Q2 40 6.66 M $68.5 M
2021 Q1 48 7.20 M $81.4 M
2020 Q4 51 7.26 M $78.3 M
2020 Q3 49 7.08 M $65.5 M
2020 Q2 48 6.97 M $66.6 M
2020 Q1 35 6.47 M $47.8 M
2019 Q4 35 5.78 M $48.1 M
2019 Q3 35 5.73 M $32.4 M
2019 Q2 41 8.03 M $62.9 M
2019 Q1 40 6.15 M $60.2 M
2018 Q4 48 6.15 M $48.1 M
2018 Q3 39 5.82 M $101 M
2018 Q2 19 4.32 M $27.4 M
2018 Q1 14 4.28 M $15.6 M
2017 Q4 14 4.16 M $16.2 M
2017 Q3 17 4.18 M $15.3 M
2017 Q2 15 4.17 M $10.7 M
2017 Q1 17 4.14 M $13.1 M
2016 Q4 11 4.32 M $10.9 M
2016 Q3 17 5.13 M $8.62 M
2016 Q2 12 5.37 M $11.5 M
2016 Q1 9 5.14 M $18.7 M
2015 Q4 12 5.14 M $18.3 M
2015 Q3 11 5.27 M $28.2 M